Native Membrane Proteins Specializes in extracting full-length membrane proteins and antigens in their native conformation with high purity, enabling pharma and biotech customers to start with high-quality targets for antibody discovery, vaccines, and structure-based drug design or high-throughput screening. Preserves native structure for GPCRs, ion channels, transporters, and viral targets to improve downstream development.

Flexible Collaboration Offers flexible engagement models including fee-for-service, risk-sharing, exclusivity options, and licensing. This supports co-development and licensing with pharma and biotech customers for high-value membrane targets. The Eurofins Discovery acquisition enhances market access and service integration.

Structure Design Provides crystallization and structure determination from full-length, functional targets without point mutations or deletions, enabling structure-driven design and fragment-based discovery. This can accelerate lead optimization by delivering accurate structural data to medicinal chemistry and computational teams.

Distributor Network Maintains an active distributor network and marketplace presence (CliniSciences, BioD, AFS BioOil; Scientist.com Marketplace) and a growing European/Global reach, offering multiple channels to reach potential buyers and fast engagement with customers through established partnerships and marketing channels.

Vaccine Antigens Focuses on native antigens and viral targets relevant to vaccines, biosensing, and diagnostic development, presenting opportunities to collaborate with vaccine developers, biotech firms, and academic groups on antigen supply, immunogen design, and related biosensing platforms.